Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Licenses offered for cell replication technology

July 30, 1997

FDA approves Niaspan for the treatment of mixed lipid disorders

July 30, 1997

Research Triangle Institute investigates compounds for male fertility control

July 30, 1997

Vivus launches new device for erectile dysfunction in the U.S.

July 29, 1997

Papaverine/phentolamine compared to PGE1 for erectile dysfunction

July 29, 1997

Unigene Laboratories and Parke-Davis to develop oral calcitonin for osteoporosis

July 29, 1997

Statins protect against stroke and CVD

July 29, 1997

Potential alternative for long-term treatment of obesity

July 28, 1997

BioTime's Hextend enters European clinical trials; licensed to Abbott

July 28, 1997

Forbes Medi-Tech submits patent, reports on clinical trials

July 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...